Safety: In September 2025, the FDA issued a statement that compounded semaglutide is risky because these products do not undergo the FDAs review for safety, effectiveness, and quality before being offered to patients
It can also be a reasonable choice when there is concern about misuse, because the prodrug design makes it less suited to the rapid effect some people seek from other stimulants
Good candidates include people with nagging sports injuries, chronic tendon or ligament pain, slow postsurgical healing, or mobility limitations from longstanding wear and tear
Working closely with a trusted healthcare provider ensures that the balance between effectiveness and comfort is maintained
Jastreboff AM, Kaplan LM, Fras JP, et al
Best session I ever had with them